Therapeutic Mechanism of Zhuyang Tongbian Decoction in Treating Functional Constipation: Insights from a Pilot Study Utilizing 16S rRNA Sequencing, Metagenomics, and Metabolomics
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Treatment outcome measurement Treatment outcome measurement,treatment outcome measurement
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- NC (Healthy Volunteers)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group was treated with Zhuyang Tongbian Decoction (ZTD) (raw drug concentration: 3.0 g/mL)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 20
- Group 1 sample size Number of subjects in the case (exposed) group
- 20
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 1 month
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- decreased
Signature 1
Source: Fig 2c
Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level
Abundance in Group 1: increased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Collinsella | ||
Desulfovibrio | ||
Romboutsia | ||
Ruminococcus | ||
UCG-002UCG-002 | ||
rumen bacterium NK4A214 |
Revision editor(s): PreciousChijioke
Signature 2
Source: Fig 2c
Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level
Abundance in Group 1: decreased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Agathobacter | ||
Faecalibacterium | ||
Fusicatenibacter | ||
Subdoligranulum | ||
Christensenellaceae_R_7_groupChristensenellaceae_R_7_group |
Revision editor(s): PreciousChijioke
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ProZY (Pro-Zhuyang Tongbian Decoction) group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 1
Source: Fig 2c
Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level
Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Agathobacter | ||
Faecalibacterium | ||
Fusicatenibacter | ||
Subdoligranulum | ||
Christensenellaceae_R_7_groupChristensenellaceae_R_7_group |
Revision editor(s): PreciousChijioke
Signature 2
Source: Fig 2c
Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level
Abundance in Group 1: decreased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Collinsella | ||
Desulfovibrio | ||
Romboutsia | ||
Ruminococcus | ||
UCG-002UCG-002 | ||
rumen bacterium NK4A214 |
Revision editor(s): PreciousChijioke
Experiment 3
Curated date: 2025/03/22
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) + ProZY (Pro-Zhuyang Tongbian Decoction)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- NC (Healthy volunteers)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Healthy volunteers with Bristol faecal character score of 4 according to the scoring criteria
Lab analysis
Statistical Analysis
- Statistical test
- LEfSe
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2
Signature 1
Curated date: 2025/03/22
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Source: Fig 4
Description: Analysis of differential flora at different taxonomic levels
Abundance in Group 1: increased abundance in NC (Healthy volunteers)
Revision editor(s): PreciousChijioke, KateRasheed
Experiment 4
Curated date: 2025/03/22
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- NC (Healthy volunteers) + ProZY (Pro-Zhuyang Tongbian Decoction)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group was treated with ZTD (raw drug concentration: 3.0 g/mL)
Lab analysis
Statistical Analysis
Signature 1
Curated date: 2025/03/22
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Source: Fig 4
Description: Analysis of differential flora at different taxonomic levels
Abundance in Group 1: increased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction)
Revision editor(s): PreciousChijioke, KateRasheed
Experiment 5
Curated date: 2025/03/22
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- NC (Healthy volunteers) + FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ProZY (Pro-Zhuyang Tongbian Decoction)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)
Lab analysis
Statistical Analysis
Signature 1
Curated date: 2025/03/23
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Source: Fig 4
Description: Analysis of differential flora at different taxonomic levels
Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction)
Revision editor(s): PreciousChijioke, KateRasheed
Experiment 6
Curated date: 2025/03/27
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- NC (Healthy Volunteers)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- FC_PreZY (Functional Constipation in Zhuyang Tongbian Decoction) group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group was treated with Zhuyang Tongbian Decoction (ZTD) (raw drug concentration: 3.0 g/mL)
Lab analysis
Statistical Analysis
- Statistical test
- Mann-Whitney (Wilcoxon)
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- Not specified
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- decreased
Signature 1
Source: Fig 3a
Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group
Abundance in Group 1: decreased abundance in FC_PreZY (Functional Constipation in Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium | ||
Lactobacillus |
Revision editor(s): PreciousChijioke
Experiment 7
Curated date: 2025/03/28
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- FC_Prezy (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ProZY (Pro-Zhuyang Tongbian Decoction) group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 1
Source: Fig 3a
Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group
Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium | ||
Lactobacillus |
Revision editor(s): PreciousChijioke
Experiment 8
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- NC (Healthy Volunteers)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- FC_PreCG (Functional Constipation in Pre-Control Group)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreCG group was treated with lactulose (manufacturer: Fresenius Kabi Austria GmbH, Austria) orally
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig 3a
Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group
Abundance in Group 1: decreased abundance in FC_PreCG (Functional Constipation in Pre-Control Group)
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium | ||
Lactobacillus |
Revision editor(s): PreciousChijioke
Experiment 9
Curated date: 2025/03/28
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- FC_PreCG (Functional Constipation in Pre-Control Group)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ProCG (Post-Control Group)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreCG group after treatment with lactulose orally
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 1
Source: Fig 3a
Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group
Abundance in Group 1: increased abundance in ProCG (Post-Control Group)
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium |
Revision editor(s): PreciousChijioke
Signature 2
Source: Fig 3a
Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group
Abundance in Group 1: decreased abundance in ProCG (Post-Control Group)
NCBI | Quality Control | Links |
---|---|---|
Lactobacillus |
Revision editor(s): PreciousChijioke
Experiment 10
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- ProZY (Pro-Zhuyang Tongbian Decoction)
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig 3a
Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group
Abundance in Group 1: increased abundance in ProCG (Post-Control Group)
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium |
Revision editor(s): PreciousChijioke
Experiment 11
Curated date: 2025/04/04
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- NC (Healthy Volunteers)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group was treated with ZTD (raw drug concentration: 3.0 g/mL)
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 1
Source: Fig 3c
Description: Comparison of significantly different flora before and after treatment with ZTD at the species level
Abundance in Group 1: increased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
uncultured bacterium |
Revision editor(s): PreciousChijioke
Signature 2
Source: Fig 3c
Description: Comparison of significantly different flora before and after treatment with ZTD at the species level
Abundance in Group 1: decreased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Escherichia coli | ||
Bifidobacterium adolescentis | ||
Faecalibacterium prausnitzii | ||
Bifidobacterium longum | ||
Bifidobacterium pseudocatenulatum | ||
gut metagenome |
Revision editor(s): PreciousChijioke
Experiment 12
Curated date: 2025/04/04
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ProZY (Pro-Zhuyang Tongbian Decoction) group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 1
Curated date: 2025/04/04
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Source: Fig 3c
Description: Comparison of significantly different flora before and after treatment with ZTD at the species level
Abundance in Group 1: decreased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
uncultured bacterium |
Revision editor(s): PreciousChijioke, KateRasheed
Signature 2
Curated date: 2025/04/05
Curator: PreciousChijioke
Revision editor(s): PreciousChijioke, KateRasheed
Source: Fig 3c
Description: Comparison of significantly different flora before and after treatment with ZTD at the species level
Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium adolescentis | ||
Bifidobacterium longum | ||
Bifidobacterium pseudocatenulatum | ||
Escherichia coli | ||
Faecalibacterium prausnitzii | ||
gut metagenome |
Revision editor(s): PreciousChijioke, KateRasheed